Why Compare Wegovy vs Mounjaro Prices in 2025?
Understanding the Wegovy Price Increase UK Landscape
The wegovy price increase UK trend has prompted many patients to explore alternative GLP-1 medications like Mounjaro. Unlike single-hormone treatments, tirzepatide (Mounjaro) targets both GIP and GLP-1 receptors, potentially offering different therapeutic benefits. However, semaglutide (Wegovy) remains the gold standard with extensive STEP trial data and established clinical pathways. The key difference isn't just mechanism—it's practical considerations like dosing flexibility, storage requirements, and long-term cost implications that matter most to patients.
EverydayMeds stocks both medications because choice matters in weight management. Where other providers focus on single products, we recognise that individual responses vary significantly between GLP-1 and dual GIP/GLP-1 therapies. This comprehensive approach means your prescriber can recommend the most suitable option based on your medical history, lifestyle, and budget considerations, rather than being limited by pharmacy stock levels or wegovy price increase UK pressures.
Wegovy vs Mounjaro Pricing Structure and Value
Despite the wegovy price increase UK concerns, EverydayMeds maintains competitive pricing for both options. Wegovy starts at £79.99 for 0.25mg with code FIRST40 applied at checkout, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for maintenance 2.4mg doses. Mounjaro follows a similar structure but with six dose levels ranging from 2.5mg to 15mg, providing greater titration flexibility for patients who need slower or more aggressive escalation schedules.
Our bundle options address the wegovy price increase UK challenge by providing supply security and convenience. The Progress Trio (0.5mg, 1mg, 1.7mg Wegovy) costs £369.99, covering three months of your dose escalation journey. For patients concerned about long-term costs, the Ultimate Stability Trio provides three 2.4mg pens for £649.99, ensuring maintenance supply without repeated ordering. Returning customers benefit from code DOSE25, whilst new customers save with FIRST40—both applied automatically at checkout to reach these final prices.
Clinical Evidence: Wegovy Price Increase UK vs Mounjaro Efficacy
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial, as reported by Wilding et al., NEJM, 2021. The STEP programme demonstrated consistent results across different patient populations, including those with type 2 diabetes and cardiovascular risk factors. Recent SELECT trial data showed 20% reduction in major cardiovascular events, adding significant clinical value beyond weight management benefits.
Mounjaro's SURMOUNT trials demonstrated potentially higher average weight loss percentages, though direct comparison isn't appropriate due to different trial designs and patient populations. What matters for patients navigating wegovy price increase UK decisions is that both medications have robust clinical evidence for long-term weight management when used alongside reduced-calorie diets and increased physical activity.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. Once injected weekly via the FlexTouch pen, it works on brain appetite centres to reduce hunger signals and promote feeling satisfied with smaller meal portions. This mechanism may also reduce food cravings, particularly for high-calorie foods, supporting sustainable dietary changes. The slow gastric emptying effect means meals feel more satisfying for longer periods, naturally supporting calorie reduction without conscious restriction. Understanding this mechanism helps explain why wegovy price increase UK concerns shouldn't overshadow the medication's proven therapeutic value as a prescription-only medicine designed for long-term weight management.
Streamlined Ordering Process Despite Wegovy Price Increase UK
EverydayMeds has simplified access to both Wegovy and Mounjaro despite ongoing wegovy price increase UK market pressures. Our 3-minute online clinical assessment covers medical history, current medications, and weight management goals, ensuring safe prescribing protocols. Prescriber review typically takes 3 working days, with express 24-hour options available for urgent requirements. Once approved, next-day delivery uses temperature-controlled cold-chain logistics, maintaining medication stability from our GPhC-registered pharmacy (#9012878) directly to your door. This efficient process means no waiting weeks for GP appointments or dealing with pharmacy stock shortages that often accompany wegovy price increase UK supply issues.
Storage and Practical Considerations
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature for up to 6 weeks once removed from refrigeration, versus Mounjaro's 21-day limit. This makes Wegovy more practical for travel, shift work, or irregular schedules where refrigerated storage isn't always available. Both medications use pre-filled pens with dose counters, but Wegovy's 5-dose escalation schedule (0.25mg to 2.4mg) is more established than Mounjaro's 6-dose range (2.5mg to 15mg). The FlexTouch pen system is identical across all Wegovy doses, reducing learning curves when escalating, whilst Mounjaro requires familiarisation with different pen types at higher doses.
Strategic Decision-Making: Wegovy Price Increase UK Impact
The wegovy price increase UK trend reflects growing demand and supply chain pressures, but shouldn't be the sole factor in medication choice. Patients who've achieved stable weight management on Wegovy may find switching medications disrupts their progress, potentially requiring restart protocols with Mounjaro's different titration schedule. Conversely, patients experiencing side effects or plateaued weight loss on Wegovy might benefit from Mounjaro's dual-hormone approach, despite similar cost structures.
EverydayMeds' dual-supply capability means you're not locked into single-medication pathways that limit clinical flexibility. Your prescriber can recommend initial therapy based on medical factors, then adjust based on response and tolerability. This approach addresses wegovy price increase UK concerns whilst prioritising clinical outcomes over cost-driven decisions that might compromise long-term weight management success.
Making Your Choice: Beyond Wegovy Price Increase UK Concerns
Both Wegovy and Mounjaro require commitment to lifestyle changes including reduced-calorie diets and increased physical activity for optimal results. The wegovy price increase UK shouldn't overshadow the reality that successful weight management is a long-term investment in health outcomes. EverydayMeds offers both options because individual responses vary—some patients respond better to pure GLP-1 stimulation, whilst others benefit from the dual GIP/GLP-1 approach. Clinical assessment through our online platform helps determine the most appropriate starting therapy, with flexibility to adjust based on your response and changing circumstances. Remember, both medications are available with discount codes FIRST40 for new customers and DOSE25 for returning patients, applied at checkout. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
